These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 35178624)
1. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Masui T; Ito T; Komoto I; Kojima S; Kasai Y; Tanabe M; Hara K; Hirano S; Okusaka T; Ichikawa Y; Kinugasa Y; Kokudo N; Kudo A; Sakurai A; Sugihara K; Date H; Haruma K; Hijioka S; Hirata K; Yamano H; Sakamine M; Kikuchi T; Fukushima M; Imamura M; Uemoto S Int J Clin Oncol; 2022 May; 27(5):840-849. PubMed ID: 35178624 [TBL] [Abstract][Full Text] [Related]
2. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. Masui T; Ito T; Komoto I; Uemoto S; BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of primary site and pathology on 903 patients with neuroendocrine neoplasms]. Qiu X; Liu M; Liu Q; Yang Z; Liu J; Meng F; Wang Z; Shi Y; Liu L; Zhang P; Luo J; Tan H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):993-996. PubMed ID: 28900988 [TBL] [Abstract][Full Text] [Related]
4. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon. Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms]. Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992 [TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: A population-based study. Zheng Z; Chen C; Jiang L; Zhou X; Dai X; Song Y; Li Y Cancer Med; 2019 Dec; 8(17):7288-7298. PubMed ID: 31609098 [TBL] [Abstract][Full Text] [Related]
7. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients. Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A; BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases]. Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989 [TBL] [Abstract][Full Text] [Related]
9. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study. Cai W; Tan Y; Ge W; Ding K; Hu H Cancer Med; 2018 Jun; 7(6):2699-2709. PubMed ID: 29733523 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations. Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D; Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962 [TBL] [Abstract][Full Text] [Related]
13. [Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms]. Li Y; Wang YF; Tan BB; Er LM; Zhao Q; Fan LQ; Zhang ZD; Liu Y Zhonghua Zhong Liu Za Zhi; 2020 May; 42(5):426-431. PubMed ID: 32482035 [No Abstract] [Full Text] [Related]
14. Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading. Cavalcanti E; Armentano R; Valentini AM; Chieppa M; Caruso ML Cell Death Dis; 2017 Aug; 8(8):e3004. PubMed ID: 28837143 [TBL] [Abstract][Full Text] [Related]
15. Correlation of World Health Organization 2010 Classification for Gastroenteropancreatic Neuroendocrine Neoplasms with the Prognosis of Ovarian Neuroendocrine Neoplasms: Kansai Clinical Oncology Group-Protocol Review Committee/Intergroup Study. Kai K; Nasu K; Nishida H; Daa T; Shikama A; Shiozaki T; Kurakazu M; Yano M; Imamura Y; Tokunaga H; Tasaki K; Iida Y; Yamada Y; Morisawa H; Nakagawa S; Fujimoto E; Tsuruta T; Matsumoto H; Arakawa A; Nonaka M; Takano H; Ushiwaka T; Mori T; Ito K; Motohashi T; Teramoto N; Yamada T Neuroendocrinology; 2021; 111(4):320-329. PubMed ID: 32097950 [TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms]. Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929 [No Abstract] [Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center. Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China. Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of patients with gastroenteropancreatic neuroendocrine neoplasms. Huang PY; Tsai KL; Liang CM; Tai WC; Rau KM; Wu KL; Huang CC; Chuah SK Kaohsiung J Med Sci; 2018 Nov; 34(11):650-656. PubMed ID: 30392572 [TBL] [Abstract][Full Text] [Related]
20. Morphological and immunohistochemical features of neuroendocrine neoplasms in gastroenteropancreatic tract. Živojinov M; Panić Ž; Ilić A; Ilić Sabo J; Vasilijević M; Lakić T Arab J Gastroenterol; 2023 Feb; 24(1):24-28. PubMed ID: 35927198 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]